Allscripts-Misys Healthcare Solutions, Inc. | |||||||||
Condensed Non-GAAP Financial Information | |||||||||
(In millions, except per-share amounts) | |||||||||
(Unaudited) | |||||||||
Non-GAAP Revenue | Three Months Ended | Nine Months Ended | |||||||
February 28, | February 28, | ||||||||
2010 | 2009 | 2010 | 2009 | ||||||
Total revenue, as reported | $179.9 | $160.7 | $514.2 | $382.1 | |||||
AHS revenue pre-merger | 0.0 | 0.0 | 0.0 | 109.3 | |||||
Deferred revenue adjustment | 0.5 | 3.1 | 4.5 | 5.2 | |||||
Elimination of prepackaged medications | 0.0 | (8.5) | 0.0 | (13.2) | |||||
Total Non-GAAP Revenue | $180.4 | $155.3 | $518.7 | $483.4 | |||||
Non-GAAP Gross Profit | Three Months Ended | Nine Months Ended | |||||||
February 28, | February 28, | ||||||||
2010 | 2009 | 2010 | 2009 | ||||||
Gross profit, as reported | $101.7 | $83.3 | $286.3 | $200.0 | |||||
AHS gross profit pre-merger | 0.0 | 0.0 | 0.0 | 61.0 | |||||
Deferred revenue adjustment | 0.5 | 3.1 | 4.5 | 5.2 | |||||
Elimination of prepackaged medications | 0.0 | (1.8) | 0.0 | (2.6) | |||||
Total Non-GAAP Gross Profit | $102.2 | $84.6 | $290.8 | $263.6 | |||||
Non-GAAP Gross Profit Margin | |||||||||
Gross margin as reported | 56.5% | 51.8% | 55.7% | 52.4% | |||||
Non-GAAP Gross margin | 56.6% | 54.5% | 56.1% | 54.5% | |||||
Non-GAAP Net Income | Three Months Ended | Nine Months Ended | |||||||
February 28, | February 28, | ||||||||
2010 | 2009 | 2010 | 2009 | ||||||
Net income, as reported | $18.5 | $13.3 | $47.2 | $12.7 | |||||
AHS net income pre-merger | 0.0 | 0.0 | 0.0 | 6.7 | |||||
Elimination of prepackaged medications | 0.0 | (1.0) | 0.0 | (2.1) | |||||
Deferred revenue adjustment | 0.5 | 3.1 | 4.5 | 5.2 | |||||
Stock-based compensation expense | 4.3 | 2.2 | 12.0 | 5.7 | |||||
Acquisition-related amortization expense | 5.6 | 6.1 | 17.0 | 14.7 | |||||
Transaction-related expense | 0.0 | 3.5 | 5.3 | 32.6 | |||||
Tax rate alignment | 0.7 | 0.0 | 0.8 | 0.0 | |||||
Non-GAAP adjustments tax effected at 39% for 2010 & 40% for 2009 | (4.0) | (5.5) | (15.1) | (22.3) | |||||
Non-GAAP Net Income | $25.6 | $21.7 | $71.7 | $53.2 | |||||
Non-GAAP Net Income Per Share - diluted | $0.17 | $0.14 | $0.48 | $0.45 | |||||
